Dr. Stephen Strickland Jr., MD is a hematologist in Nashville, Tennessee. He is the Director of Leukemia Research for the Sarah Cannon Transplant & Cellular Therapy Network. Dr. Strickland's research interests revolve around translational research and early phase clinical trials for the treatment of acute leukemia (AML , ALL) and and myeloid malignancies (MDS, MPN)  Dr. Strickland is an internationally respected leukemia researcher with more than 100 peer-reviewed scientific publications and abstracts.

He received his Doctor of Medicine from Louisiana State University School of Medicine in New Orleans and completed his internship/residency (Internal Medicine), clinical fellowship (Hematology/Oncology), and a Master of Science in Clinical Investigation at Vanderbilt University Medical Center.